Suchergebnisse - "Mushtaq, Muhammad Umair"

PubPharm (8)

1

Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

enthalten in: Leukemia & lymphoma | 2024

von Mushtaq, M. | Shahzad, M. | Amin, M. | +12

2

Lessons learned from COVID-19 pandemic : outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients

enthalten in: Leukemia & lymphoma | 2023

von Al-Ramahi, J. | Shahzad, M. | Li, K. | +12

3

Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years : a systematic review

enthalten in: Leukemia & lymphoma | 2023

von Shahzad, M. | Chaudhary, S. | Tariq, E. | +12

4

Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia : a systematic review and meta-analysis

enthalten in: Leukemia & lymphoma | 2022

von Shahzad, M. | Tariq, E. | Chaudhary, S. | +10

5

Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes : a systematic review and meta-analysis

enthalten in: Leukemia & lymphoma | 2022

von Khanam, R. | Shahzad, M. | Chaudhary, S. | +15

6

Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapies

enthalten in: Leukemia & lymphoma | 2022

von Siddiqui, R. | Chaudhary, S. | Shahzad, M. | +12

7

Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia

enthalten in: Leukemia & lymphoma | 2021

von Mushtaq, M. | Harrington, A. | Chaudhary, S. | +12

8

Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma

enthalten in: Leukemia & lymphoma | 2019

von Dhakal, B. | Pagenkopf, A. | Mushtaq, M. | +10

1
[1]